KETAMINE
Clinical trials for KETAMINE explained in plain language.
Never miss a new study
Get alerted when new KETAMINE trials appear
Sign up with your email to follow new studies for KETAMINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to quiet ICU delirium faster
Symptom relief Not yet recruitingThis study tests whether combining two sedative drugs (esketamine and dexmedetomidine) can safely reduce the time ICU patients spend in a confused, agitated state called hyperactive delirium. About 132 adults on non-invasive breathing support will receive either the drug combo or…
Matched conditions: KETAMINE
Phase: PHASE4 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Symptom relief
Last updated May 26, 2026 08:39 UTC
-
Heart surgery pain breakthrough? ketamine may stop chronic ache
Symptom relief Not yet recruitingThis study tests whether giving a single dose of ketamine during open-heart surgery can reduce chronic pain that sometimes lasts for months after the operation. About 100 adults having planned heart surgery will be randomly assigned to receive either ketamine or a placebo during …
Matched conditions: KETAMINE
Phase: NA • Sponsor: Bursa City Hospital • Aim: Symptom relief
Last updated May 26, 2026 08:32 UTC
-
No opioids, better recovery? new anesthesia approach for elderly heart surgery
Symptom relief Not yet recruitingThis study looks at whether avoiding opioids during anesthesia can help elderly patients recover faster after coronary artery bypass surgery. Researchers will compare opioid-free anesthesia to standard opioid-based anesthesia in 60 patients aged 65 and older. The goal is to see i…
Matched conditions: KETAMINE
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC
-
Can a single dose or a simple plan stop suicide? major trial launches in brazil
Symptom relief Not yet recruitingThis study compares two promising strategies to prevent suicide: a single infusion of esketamine (a fast-acting medication) and a one-session Crisis Response Planning session where a clinician helps create a personal safety plan. Both are added to standard care. Researchers will …
Matched conditions: KETAMINE
Phase: PHASE4 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated May 20, 2026 11:53 UTC